tyrosine has been researched along with metoprolol in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bellman, K; Knegtel, RM; Settimo, L | 1 |
| Adlerberth, A; Angerås, U; Hasselgren, PO; Stenström, G | 1 |
| Böger, RH; Fahlbusch, SA; Frölich, JC; Gutzki, FM; Mehls, C; Stichtenoth, DO; Tsikas, D | 1 |
| Ceron, CS; Gerlach, RF; Guimaraes, DA; Martins-Oliveira, A; Pinheiro, LC; Prado, CM; Rizzi, E; Tanus-Santos, JE | 1 |
1 trial(s) available for tyrosine and metoprolol
| Article | Year |
|---|---|
Effects of carvedilol on oxidative stress in human endothelial cells and healthy volunteers.
Topics: Adrenergic Antagonists; Adult; Antioxidants; Carbazoles; Carvedilol; Cells, Cultured; Cross-Over Studies; Dinoprost; Dinoprostone; Double-Blind Method; Endothelial Cells; Humans; Isoprostanes; Lipoproteins, LDL; Male; Metoprolol; Oxidative Stress; Propanolamines; Reactive Nitrogen Species; Reactive Oxygen Species; Thiobarbituric Acid Reactive Substances; Tyrosine | 2004 |
3 other study(ies) available for tyrosine and metoprolol
| Article | Year |
|---|---|
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
Protein metabolism in skeletal muscle tissue from hyperthyroid patients after preoperative treatment with antithyroid drug or selective beta-blocking agent. Results from a prospective, randomized study.
Topics: Adrenergic beta-Antagonists; Adult; Antithyroid Agents; Female; Humans; Hyperthyroidism; Male; Metoprolol; Middle Aged; Muscle Proteins; Muscles; Preoperative Care; Random Allocation; Thyroidectomy; Thyroxine; Tyrosine | 1984 |
β1-Adrenergic blockers exert antioxidant effects, reduce matrix metalloproteinase activity, and improve renovascular hypertension-induced cardiac hypertrophy.
Topics: Adrenergic beta-1 Receptor Antagonists; Animals; Antihypertensive Agents; Antioxidants; Benzopyrans; Blood Pressure; Down-Regulation; Ethanolamines; Hypertension, Renovascular; Hypertrophy, Left Ventricular; Kidney; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase Inhibitors; Metoprolol; Nebivolol; Oxidative Stress; Phosphorylation; Proto-Oncogene Proteins c-akt; Random Allocation; Rats; Rats, Wistar; Reactive Oxygen Species; Tyrosine; Ventricular Remodeling | 2014 |